KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.84.

  • Amneal Pharmaceuticals' Asset Utilization Ratio rose 868.92% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 868.92%. This contributed to the annual value of 0.8 for FY2024, which is 2171.18% up from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Asset Utilization Ratio is 0.84, which was up 868.92% from 0.84 recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.84 for Q2 2025, and its period low was 0.5 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.65, with a median of 0.63 in 2023.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Asset Utilization Ratio surged by 2521.28% in 2021 and then skyrocketed by 384.38% in 2022.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Asset Utilization Ratio stood at 0.53 in 2021, then rose by 8.98% to 0.58 in 2022, then rose by 15.96% to 0.67 in 2023, then rose by 20.03% to 0.8 in 2024, then grew by 4.15% to 0.84 in 2025.
  • Its last three reported values are 0.84 in Q3 2025, 0.84 for Q2 2025, and 0.82 during Q1 2025.